Daiki Birukawa

Title: Daiki Birukawa: Innovator in Pharmaceutical Preparations

Introduction

Daiki Birukawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable preparations containing saxagliptin.

Latest Patents

Birukawa holds 2 patents, with his latest invention focusing on a preparation containing saxagliptin. This preparation is designed to have improved stability and includes a method for producing the same. The invention features a plain tablet part that contains one or more first additive agents selected from a group consisting of D-mannitol, lactose, anhydrous lactose, and anhydrous dibasic calcium phosphate. Notably, the plain tablet part contains less than 35% by weight of crystalline cellulose with respect to 100% by weight of the plain tablet part. Additionally, a film coating part is in contact with the plain tablet part and contains saxagliptin, a salt thereof, or a hydrate thereof.

Career Highlights

Daiki Birukawa is currently employed at Sawai Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on innovative pharmaceutical solutions that enhance drug stability and efficacy.

Collaborations

Throughout his career, Birukawa has collaborated with talented individuals such as Kenji Nozawa and Wataru Izui. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Daiki Birukawa is a prominent figure in the pharmaceutical industry, recognized for his innovative work on saxagliptin preparations. His contributions continue to impact the field positively, showcasing the importance of research and development in pharmaceuticals.